Avantor (AVTR): Director received 6,225 shares
Simon Dingemans, Director at Avantor, reported a grant / award of 6,225 shares.
- 6,225
- Shares
- Traded
- Jan 2, 2026
- Filed
- Jan 12, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 26, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On November 10, 2025, the Company, announced the appointment Mary Blenn as Executive Vice President and Chief Operating Officer. Ms. Blenn is a member of the Company’s Executive Leadership Team.”
- Nov 17, 2025Insider · Their first buy on recordCEO purchased ~$993K of AVTR shares in the open market
- Dec 4, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On December 4, 2025, the Board of Directors (the “Board”) of Avantor, Inc. (the “Company”), upon the recommendation of its Nominating and Governance Committee, elected Sanjeev Mehra as a director with an initial term expiring on the date of the Company’s 2026 Annual Meeting of Stockholders.”
- Dec 4, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 4, 2025, Avantor, Inc. (the “Company”) filed a Current Report on Form 8-K announcing the election of Sanjeev Mehra as a director of the Company effective December 4, 2025.”
- Dec 5, 2025Insider · Largest insider buy since 2019Director purchased ~$3.88M of AVTR shares in the open market
- Dec 17, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On December 17, 2025, the Board of Directors (the “Board”) of Avantor, Inc. (the “Company”), upon the recommendation of its Nominating and Governance Committee, elected Simon Dingemans as a director, effective January 2, 2026, with an initial term expiring on the date of the Company’s 2026 Annual Meeting of Stockholders.”
- Dec 17, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 17, 2025, Avantor, Inc. (the “Company”) filed a Current Report on Form 8-K announcing the election of Simon Dingemans as a director of the Company effective January 2, 2026.”
What came next
- Feb 11, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Feb 12, 2026InsiderDirector purchased ~$940K of AVTR shares in the open market
- Feb 19, 2026Insider · Their first buy on recordDirector purchased ~$458K of AVTR shares in the open market
- Mar 10, 2026InsiderDirector purchased ~$1M of AVTR shares in the open market
- Mar 26, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 26, 2026, Mr. R. Brent Jones notified Avantor, Inc. (the “Company”) of his decision to resign as the Company’s Executive Vice President and Chief Financial Officer (“CFO”) to join a company outside the life sciences industry.”
- Apr 17, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 17, 2026, Avantor, Inc. (the “Company”) informed Benoit Gourdier, the Company’s Executive Vice President, Bioscience and Medtech Products, that he would be transitioning to a new role supporting the Company’s segment integration activities, after which it is expected that he would depart the Company no later than December 31, 2026.”
- Apr 29, 2026Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Avantor
For Avantor, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AVTR page.
Other recent filings by Simon Dingemans, Director
The full history of Simon Dingemans, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Avantor (AVTR) insider traded, and how much?
Simon Dingemans, Director at Avantor, reported a grant / award of 6,225 shares. Not an open-market trade.
When did it happen, and when was it made public?
Traded: Jan 2, 2026. Filed: Jan 12, 2026. That is 10 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Avantor recently?
For Avantor, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days. They are listed on the AVTR page.
Does this mean AVTR stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Avantor
- SEC Form 13F-HRNov 16, 2026
- USAspending.gov award recordAug 31, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its AVTR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data